FDA Drug Recalls

Recalls / Class II

Class IID-0191-2021

Product

fentaNYL 100 mcg/50mL Ropivacaine HCl 0.1% in 0.9% Sodium Chloride 50 mL, 50 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004026422

Affected lot / code info
Lot # 1220023275, BUD 2/15/2021; 1220023312, BUD 2/15/2021; 1220023433, 2/22/2021; 1220023515, BUD 2/24/2021 & 1220023671, BUD 3/1/2021.

Why it was recalled

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Recalling firm

Firm
SCA Pharmaceuticals
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
755 Rainbow Rd Ste B, Windsor, Connecticut 06095-1024

Distribution

Quantity
1,774 syringes
Distribution pattern
Product was distributed to hospitals nationwide.

Timeline

Recall initiated
2020-12-17
FDA classified
2021-01-07
Posted by FDA
2021-01-13
Terminated
2021-11-02
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0191-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls